Table 1.

Participant baseline characteristics and between-group differences

	All participants	Non-faller	Faller
	(n = 81)	(n = 58)	(n = 23)	Test	P-value
Demographics
Country (Singapore)	56 (69.1%)	42 (72.4%)	14:9 (60.9%)	3	0.310
Age	62.99 ± 13.22	62.83 ± 12.29	63.39 ± 15.63	1	0.864
Sex (male)	43 (53.1%)	31 (53.4%)	12 (52.2%)	3	0.917
Stroke details
Time since stroke (days)	24.0 (20.0–34.5)	23.0 (20.0–33.3)	24.0(22.0–36.0)	2	0.515
Side of stroke lesion (right)	39 (48.1%)	27 (46.6%)	12 (52.2%)	3	0.771
Type of stroke (infarct)	64 (79.0%)	46 (79.3%)	18 (78.3%)	3	0.917
Functional measures, comorbidities and falls history
Modified Rankin Scale (0–6)	2.83 ± 0.89	2.67 ± 0.91	3.22 ± 0.74	2	0.013*
FIM (18–126)	105.0 (93.0–116.5)	105.5 (94.0–118.0)	103.0 (92.0–115.0)	2	0.753
MoCA (0–30) (n = 78)	25.0 (23.0–28.0)	25.0 (23.0–27.0)	26.0 (20.8–28.0)	2	0.902
Inattention, star cancellation test < 44 (yes) (n = 80)	15 (18.8%)	11 (19.3%)	4 (17.4%)	3	0.843
HADS (0–21) (n = 77)	7.0 (3.0–12.0)	7.0 (3.0–12.5)	7.0 (3.0–11.5)	2	0.977
Short FES-I (7–28)	10.0 (8.0–15.0)	9.5 (7.0–14.0)	13.0 (10.0–19.0)	2	0.013*
Gait aid use (yes)	19 (23.5%)	11 (19.0%)	8 (34.8%)	3	0.130
Assistance for gait (yes)	16 (19.8%)	10 (20.8%)	6 (26.1%)	3	0.367
FCI (0–18)	1.60 ± 0.74	1.52 ± 0.71	1.83 ± 0.78	2	0.064
Prior stroke	5 (6.2%)	1 (1.7%)	4 (17.4%)	3	0.008*
Inpatient falls (yes)	15 (18.5%)	8 (13.8%)	7 (30.4%)	3	0.082
≥1 fall in 12 months preceding stroke (yes)	19 (23.5%)	10 (17.2%)	9 (39.1%)	3	0.046*

*Denotes a significance at P < 0.05

Abbreviations, FCI Functional Comorbidity Index, FES-I Falls Efficacy Scale – International, FIM Functional Independence Measure, HADS Hospital Anxiety and Depression Scale, MoCA Montreal Cognitive Assessment

Note: Data presented as mean ± SD, median (IQR) or N (%), Test 1 independent t-test, Test 2 Mann-Whitney U test, Test 3 Chi-Square test